NCT06841016Completed
Virtual Nephrologist
An Interactive, Conversational Virtual Healthcare Agent to Educate and Engage Patients With Advanced Chronic Kidney Disease About Transplantation (Part 2: Pilot)
Source: ClinicalTrials.gov · Last updated 12 Jan 2026
Brief summary (registry, in English)
To develop, pilot, and refine a virtual healthcare agent that will educate patients with advanced chronic kidney disease and their caregivers about kidney transplantation.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 148 (actual)
- First submitted
- 10 Feb 2025
- Start date
- 26 Mar 2024
- Primary completion date
- 14 Jul 2025
- Lead sponsor
- University of Pennsylvania
- Diseases
- Chronic kidney disease
- NCT number
- NCT06841016
What you commit to
- Study type: Interventional
- Participants enrolled: 148
- From 26 Mar 2024 to the primary completion date, 14 Jul 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Vulnerable populations
Who the study is looking for
- 18 y/o able to provide consent
- Advanced CKD
- English speaking
- Penn Medicine patient
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Vanderbilt University Medical Center Coordinator of this site? Confirm its status | Nashville | United States | Unknown status |
| Hospital of the University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
Related publications
- An Interactive Virtual Nephrologist to Engage Patients With Advanced CKD About Transplantation.Am J Kidney Dis · 2026 · PMID 42448023
This page is information, not medical advice. Discuss any trial with your doctor.